Researching Resiliency in Stressful Experiences (RISE) Program for Men Leaving Incarceration

NCT04785677 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 403

Last updated 2026-03-11

Study results available
· View outcomes & findings →

Summary

The investigators are conducting a randomized controlled trial to assess the impact of Resiliency in Stressful Experiences (RISE) - a comprehensive trauma-based program for young men releasing from a southeastern state's prisons. The investigators are assessing whether treating trauma and providing other transitional supports - such as employment assistance - as young men return home will help to improve their community stability and enhance their psychological well-being, in turn, resulting in less likelihood that a person will become incarcerated in the future.

Conditions

  • Stress Disorders, Traumatic
  • Stress Disorders, Traumatic, Acute
  • Depressive Symptoms
  • Anxiety
  • Substance Use
  • Aggression
  • Coping Skills
  • Impulsive Behavior
  • Housing Problems
  • Recidivism
  • Stress
  • Occupational Stress
  • Psychological Distress

Interventions

BEHAVIORAL

Resiliency in Stressful Experiences (RISE) Program

The Resiliency in Stressful Experiences (RISE) Program is a multi-phased comprehensive trauma based reentry program designed based on the transitional nature of reentry. Participants will receive up to 4 sessions prior to release and up tp 15 session post release from prison. The RISE program is a trauma intervention paired with reentry services, including housing support and employment assistance.

Sponsors & Collaborators

Principal Investigators

  • Carrie Pettus-Davis, PhD · Florida State University College of Social Work, Institute of Justice Research & Development

  • Stephen Tripodi, PhD · Florida State University College of Social Work, Institute of Justice Research & Development

  • Tanya Renn, PhD · Florida State University College of Social Work, Institute of Justice Research & Development

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-09
Primary Completion
2023-05-30
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04785677 on ClinicalTrials.gov